ArticleMaterials today. Bio2026
Enhanced functional mitochondrial donation through glucose-responsive antioxidant microcarrier-engineered native-like MSCs accelerates diabetic wound healing.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes impairs wound healing due to hyperglycemia-induced vascular dysfunction. This condition triggers mitochondrial impairment, leading to ferroptosis in endothelial cells. While mesenchymal stromal cells (MSCs) can promote tissue repair through intercellular mitochondrial transfer, strategies to enhance their mitochondrial-donating capacity under hyperglycemic conditions remain underdeveloped. Mesenchymal condensation endows MSCs with enhanced regenerative potential and greater mitochondrial functionality. Microcarrier-based three-dimensional (3D) dynamic culture systems mimicking this process offer a promising strategy. However, effectively shielding donor MSCs from hyperglycemia-induced oxidative stress remains a key challenge in microcarrier design. Here, we engineered a glucose-responsive antioxidant biomaterial-based 3D dynamic culture system using chitosan-formylphenylboronic acid (CS-FPBA) microcarriers combined with stem cells from human exfoliated deciduous teeth (SHED) to generate native-like SHED (N-SHED). This system provides a protective niche for transplanted SHED through glucose-triggered antioxidant microcarrier degradation while simultaneously enhancing mitochondrial function and intercellular transfer. Consequently, N-SHED attenuated endothelial ferroptosis, promoted angiogenesis, and accelerated diabetic wound healing in vivo. This study presents a native-like cell culture platform that amplifies the therapeutic efficacy of MSCs by enhancing their mitochondrial-donating capacity. With strong translational potential, this strategy not only advances MSCs-based therapy for diabetic wounds but also offers a novel framework for mitochondrial-targeted regenerative medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.